Lyvispah
- Product NDC
- 70257-414
- 11-digit product format
- 702570414
- Labeler code
- 70257
- Product ID
- 70257-414_c2cbebf8-e2d6-4515-adbe-c3f7e5091a1b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- baclofen
- Dosage form
- GRANULE
- Route
- ORAL
- Labeler
- Saol Therapeutics Inc
- Application
- NDA215422
- Marketing category
- NDA
- Marketing start
- 2021-11-22
- Marketing end
- 0000-00-00
- Substance
- BACLOFEN
- Active strength
- 10 mg/1
- Pharmacologic classes
- GABA A Agonists [MoA],GABA B Agonists [MoA],gamma-Aminobutyric Acid-ergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70257-414-87 | Lyvispah | 90 in 1 BOTTLE, UNIT-DOSE | GRANULE | 90 | | 2 |
| 70257-414-87 | Lyvispah | 1 in 1 PACKET | GRANULE | 1 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70257-414 | LYVISPAH (BACLOFEN) GRANULE [SAOL THERAPEUTICS INC] | 2 | Legacy NDC, 2 package rows | 20230115_a7d2dc58-e167-4ebc-ac1d-932f000fb412.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70257-414-87 | 70257041487 | 90 PACKET in 1 BOTTLE, UNIT-DOSE (70257-414-87) > 1 GRANULE in 1 PACKET | 90 packet | 2021-11-22 | 0000-00-00 | No | No | Current |